High mRNA expression of OAS2 (HR = 0.26, 95%CI: 0.1–0.67, p = 0.0027), OAS3 (HR = 0.43, 95%CI: 0.26–0.7, p < 0.001), and OASL (HR = 0.47, 95%CI: 0.27–0.83, p = 0.0078) was correlated with better OS in basal-like breast cancer (Fig. 3b-d). This evidence concerns the gene OAS3 and breast carcinoma.